13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-05-20 Event 2025-05-08 SEC 0000899140-25-000717 →

DONG-A ST CO., LTD MetaVia Inc. MTVA

Stake: 51.10% Shares: 9,995,679 CUSIP: 64132R404 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of this Schedule 13D is hereby amended and supplemented to include the following: Securities Purchase Agreement and Warrants On May 8, 2025, the Reporting Persons entered into a Securities Purchase Agreement with the Issuer (the "Securities Purchase Agreement") pursuant to which (i) DA ST agreed to purchase from the Issuer 4,647,887 shares of Common Stock, and (ii) DA Socio agreed to purchase from the Issuer (a) 4,831,458 shares of Common Stock, and (b) Pre-Funded Warrants to acquire 4,605,162 shares of Common Stock (the "Warrants"), in each case for the purchase price set forth in the Securities Purchase Agreement. The Warrants become exercisable for shares of Common Stock upon obtaining the requisite approval of the Issuer's stockholders in accordance with applicable Nasdaq listing rules (the "Stockholder Approval"). In addition, pursuant to the Securities Purchase Agreement, the Issuer agreed to call a meeting of stockholders not later than 60 days after the closing under the Securities Purchase Agreement to obtain the Stockholder Approval. In the event that the Issuer does not obtain the Stockholder Approval at the first stockholder meeting, the Issuer is obligated to hold a meeting every four months thereafter until the Stockholder Approval is obtained. The Warrants contain a provision which precludes exercise of the Warrants to the extent that, following exercise, DA Socio, together with its affiliates and other attribution parties, including DA ST, would own more than 19.99% of the Common Stock outstanding. The foregoing descriptions of the Securities Purchase Agreement and Warrants are qualified in their entirety by the terms and conditions of the Securities Purchase Agreement and Warrants, as applicable, filed as Exhibits 99.1 and 99.2 hereto and which are incorporated by reference herein. Registration Rights Agreement In connection with entering into the Securities Purchase Agreement, on May 8, 2025, the Reporting Persons and the Issuer entered into a registration rights agreement (the "2025 Registration Rights Agreement"). The 2025 Registration Rights Agreement provides the Reporting Persons with demand registration rights, and the Issuer agreed to file a resale registration statement to register the shares of Common Stock issued under the Securities Purchase Agreement and issuable upon exercise of the Warrants (subject to obtaining the Stockholder Approval). The foregoing description of the 2025 Registration Rights Agreement is qualified in its entirety by the terms and conditions of the 2025 Registration Rights Agreement, which is filed as Exhibit 99.3 hereto and incorporated by reference herein.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 1.00
56,743 shares short · +22.9% vs prior

Other 13D/G Filings on MetaVia Inc.

FiledFormFilerStakeShares
2022-09-23 SC JK BioPharma Solutions, Inc view →
2022-09-16 SC DONG-A ST CO., LTD view →
2022-08-05 SC E&Investment, Inc. view →
2021-11-10 SC JK BioPharma Solutions, Inc view →
2021-09-01 SC DONG-A ST CO., LTD view →
2021-08-30 SC DONG-A ST CO., LTD view →
2021-08-30 SC E&Investment, Inc. view →
2020-01-16 SC NEUROBO THERAPEUTICS, INC. view →

Other Filings by DONG-A ST CO., LTD

FiledFormIssuerStakeShares
2022-09-16 SC NeuroBo Pharmaceuticals, Inc. MTVA view →
2021-09-01 SC NeuroBo Pharmaceuticals, Inc. MTVA view →
2021-08-30 SC NeuroBo Pharmaceuticals, Inc. MTVA view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →